Investigating the optimal size of anticancer nanomedicine
Investigating the optimal size of anticancer nanomedicine
About this item
Full title
Author / Creator
Tang, Li , Yang, Xujuan , Yin, Qian , Cai, Kaimin , Wang, Hua , Chaudhury, Isthier , Yao, Catherine , Zhou, Qin , Kwon, Mincheol , Hartman, James A. , Dobrucki, Iwona T. , Dobrucki, Lawrence W. , Borst, Luke B. , Lezmi, Stéphane , Helferich, William G. , Ferguson, Andrew L. , Fan, Timothy M. and Cheng, Jianjun
Publisher
United States: National Academy of Sciences
Journal title
Language
English
Formats
Publication information
Publisher
United States: National Academy of Sciences
Subjects
More information
Scope and Contents
Contents
Significance Understanding the interdependency of physiochemical properties of nanomedicine (NM) in correlation to its biological response and function is crucial for additional development of anticancer NM. Here, we prepared monodisperse drug–silica nanoconjugates in three distinct sizes (20, 50, and 200 nm) with other physiochemical properties co...
Alternative Titles
Full title
Investigating the optimal size of anticancer nanomedicine
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_25316794
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_25316794
Other Identifiers
ISSN
0027-8424
E-ISSN
1091-6490
DOI
10.1073/pnas.1411499111
